The Charité - Universitätsmedizin Berlin and the Technical University of Berlin are planning to establish a strategic partnership to develop a new joint research campus in Berlin-Wedding.

Alzheimer's disease is a neurodegenerative disease. The increasing aggregation of beta-amyloids let nerve cells die in the brain. A British research team led by Prof. Michele Vendruscolo from the Department of Chemistry  of the University of Cambridge now found that cholesterol in the cells plays an important role in this aggregation process.

The American start-up company Hesperos Inc. from Florida has developed a neuromuscular in vitro model which can be used to investigate pharmaceuticals to treat neuromuscular diseases  as well as to test nerve toxins such as botulinum toxin.

A research team led by Prof. Yixin Zhang from the Center for Molecular Bioengineering ("BCUBE") at Dresden University of Technology has developed a platform called screenMATRIX. It consists of polymer matrices containing defined chemical components that offers a cells growth in a more nature-like environment.

The European Commission intends to allocate euros 97.6 billion to the Horizon Europe research programme over the next seven years. This is about 30 percent more than for the current Horizon 2020, but less than lobby organizations had expected.

As reported by the Thüringer Allgemeine Zeitung online in its current issue, an award for the development of alternative methods to animal experiments will be given for the first time as of 2019. The prize is endowed with a maximum of 12,000 euros.

The National Toxicology Program (NTP) Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) is currently requesting available data and information on approaches and/or technologies currently used to identify potential developmental toxicants. 

In collaboration with scientists from the Henkel in vitro laboratory, researchers from the Institute of Biochemistry and Molecular Biology I at Heinrich-Heine-University Düsseldorf led by Prof. Peter Brenneisen have developed a model of aged skin. The model can be used for many purposes, such as toxicity or drug testing.

A German-British team of researchers has found that the amniotic fluid during the human pregnancy contains mesenchymal stem cells of the kidney of the fetus. The cells are well suited to develop
three-dimensional renal organoids from them for toxicological studies and research into kidney diseases.

MEPs yesterday adopted a resolution to support a ban of animal testing worldwide for cosmetic purposes.